Literature DB >> 17174011

Platelet beta-secretase activity is increased in Alzheimer's disease.

J A Johnston1, W W Liu, D T R Coulson, S Todd, S Murphy, S Brennan, C J Foy, D Craig, G B Irvine, A P Passmore.   

Abstract

beta-Secretase activity is the rate-limiting step in Abeta peptide production from amyloid precursor protein. Abeta is a major component of Alzheimer's disease (AD) cortical amyloid plaques. beta-Secretase activity is elevated in post mortem brain tissue in AD. The current study investigated whether beta-secretase activity was also elevated in peripheral blood platelets. We developed a novel fluorimetric beta-secretase activity assay to investigate platelets isolated from individuals with AD (n=86), and age-matched controls (n=115). Platelet membrane beta-secretase activity (expressed as initial rate) varied over fourfold between individuals, raising important questions about in vivo regulation of this proteolytic activity. Nonetheless, we identified a significant 17% increase in platelet membrane beta-secretase activity in individuals with AD compared to controls (p=0.0003, unpaired t-test). Platelet membrane beta-secretase activity did not correlate with mini-mental state examination (MMSE) score in the AD group (mean MMSE=17.7, range 1-23), indicating that the increase did not occur as a secondary result of the disease process, and may even have preceded symptom onset.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174011     DOI: 10.1016/j.neurobiolaging.2006.11.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  22 in total

1.  Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease.

Authors:  Victor L Villemagne; Keyla A Perez; Kerryn E Pike; W Mei Kok; Christopher C Rowe; Anthony R White; Pierrick Bourgeat; Olivier Salvado; Justin Bedo; Craig A Hutton; Noel G Faux; Colin L Masters; Kevin J Barnham
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 2.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

3.  BACE1 polymorphisms do not influence platelet membrane beta-secretase activity or genetic susceptibility for Alzheimer's disease in the Northern Irish population.

Authors:  S Todd; A J McKnight; W W Liu; R Carson; S Heggarty; B McGuinness; G B Irvine; D Craig; A P Passmore; J A Johnston
Journal:  Neuromolecular Med       Date:  2008-06-26       Impact factor: 3.843

4.  Variation in RTN3 and PPIL2 genes does not influence platelet membrane beta-secretase activity or susceptibility to alzheimer's disease in the northern Irish population.

Authors:  Robyn Carson; Amy Jayne McKnight; Stephen Todd; Wei Wei Liu; Shirley Heggarty; David Craig; Bernadette McGuinness; G Brent Irvine; A Peter Passmore; Janet A Johnston
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

5.  Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern.

Authors:  Sérgio M de Almeida; Clea E Ribeiro; Indianara Rotta; Scott Letendre; Michael Potter; Bin Tang; Meiri Batistela; Florin Vaida; Ronald J Ellis
Journal:  J Neurovirol       Date:  2019-07-07       Impact factor: 2.643

Review 6.  BACE1 as a potential biomarker for Alzheimer's disease.

Authors:  Boris Decourt; Marwan N Sabbagh
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  An apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide beta 42.

Authors:  Ioannis Dafnis; Efstratios Stratikos; Athina Tzinia; Effie C Tsilibary; Vassilis I Zannis; Angeliki Chroni
Journal:  J Neurochem       Date:  2010-11       Impact factor: 5.372

Review 8.  Role of platelets in neuroinflammation: a wide-angle perspective.

Authors:  Lawrence L Horstman; Wenche Jy; Yeon S Ahn; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; J Steven Alexander; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2010-02-03       Impact factor: 8.322

9.  Adhesion of monocytes to type I collagen stimulates an APP-dependent proinflammatory signaling response and release of Abeta1-40.

Authors:  Cindy M Sondag; Colin K Combs
Journal:  J Neuroinflammation       Date:  2010-03-19       Impact factor: 8.322

10.  Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer's disease.

Authors:  Carlo Cervellati; Alessandro Trentini; Valentina Rosta; Angelina Passaro; Cristina Bosi; Juana Maria Sanz; Stefania Bonazzi; Salvatore Pacifico; Davide Seripa; Giuseppe Valacchi; Remo Guerini; Giovanni Zuliani
Journal:  Geroscience       Date:  2019-11-19       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.